their respective non-contacting controls. Multivariate Cox survival analyses revealed GBM contact with the VSVZ, but not SGZ, CC, or cortex, as an independent predictor of lower OS, PFS, and early recurrence. We hypothesize that the VSVZ niche has unique properties that contribute to GBM pathobiology in adults.
Introduction
The ventricular-subventricular zone (VSVZ) [1, 2] and subgranular zone (SGZ) [3] are neurogenic zones that harbor neural stem cells in the adult human brain. The VSVZ, the larger of the two regions, is located in the lateral walls of the lateral ventricles, while the SGZ is found in hippocampal dentate gyrus [1] [2] [3] [4] .
Several studies have demonstrated that glioblastoma (GBM) tumor cells exhibit a tropism for the VSVZ by spreading along the white matter tracts, specifically the corpus callosum (CC) [5] [6] [7] . Patients with GBMs spreading along the CC have been shown to have a decreased survival, [8] [9] [10] [11] although the basis of this effect remains unclear. While some studies suggest a greater malignant potential of GBMs with VSVZ contact (VSVZ+GBMs), the majority of these studies were conducted on small cohorts (<100 total patients) [12] . Further, these clinical data cumulatively are limited by the heterogeneous adjustments for the common, well-known survival confounders and other clinical variables such as extent of resection and tumor volume [12] [13] [14] [15] [16] [17] [18] . On the other hand, the clinical impact of GBM contact with SGZ is unexplored.
A report by Lim et al., proposed an interaction between the VSVZ and cortical contact, classifying GBMs into 4 groups-VSVZ+/cortex+, VSVZ+/cortex−, VSVZ−/cortex+, and VSVZ−/cortex− -based on the observation that VSVZ+/cortex+ GBMs were most likely to be multifocal and have distal recurrences compared to VSVZ−/cortex− GBMs [19] . While this classification is commonly used, [20] [21] [22] [23] whether an interaction between VSVZ and cortex exists that is predictive of survival, tumor multifocality, and distal recurrences remains uninvestigated.
Therefore, we studied the influence on survival of radiographic contact of GBM with the two neurogenic zones as well as the CC to answer three main questions: first, does GBM contact with the neurogenic zones decrease patient survival, and if so, is this effect specific to a particular neurogenic zone? Second, is radiographic contact with or invasion of the CC by GBM associated with a decreased survival? And finally, is there an interaction between VSVZ and cortex that is predictive of survival, tumor multifocality, and distal recurrence?
Methods

Patient population selection
This study was conducted in accordance with the ethics and regulations of Vanderbilt University Medical Center and was approved by the Institutional Review Board. We retrospectively identified 207 adult (≥18 years of age) patients enrolled in our institutional tumor registry after informed consent who underwent a cytoreductive surgery for pathology-proven supratentorial GBM (WHO grade IV glioma) between 2001 and 2014. Patients were followed through January 2016. Those who underwent non-resective biopsies or who had incomplete medical records lacking preoperative clinical data and pre-and immediate postoperative imaging were excluded. All patients underwent a maximal safe resection of their GBM by four specialized tumor neurosurgeons followed by treatment with chemotherapy (temozolomide) and radiation.
Clinical data collection
Patients' age at the time of surgery, sex, preoperative Karnofsky performance status score (KPS; 0-100 in increments of 10), extent of tumor resection (EOR), time to death or last follow-up, and time to radiographic progression or last MRI without progression were collected. KPS was assigned by a physician at the time of evaluation. EOR was evaluated independently by both a neurosurgeon and neuroradiologist on the basis of MRI obtained within 24 hours of surgery. Gross total resection (GTR) was defined as having no residual contrast enhancement. Near total resection (NTR) was defined as enhancing tumor residual of less than 5% or when the senior radiologist could not rule out minute residual tumor. Subtotal resection (STR) was defined as a resection of less than 95% of the enhancing tumor. Overall survival (OS) was calculated as the time to death from any cause. Progression free survival (PFS) was calculated as the time to first definitive radiographic disease progression confirmed by neuroradiologist and neuro-oncologist without suspicion for pseudoprogression or as the time of death if no radiographic progression was noted.
Radiological data collection
Patients' preoperative (<3 weeks) T1-weighted gadolinium-enhanced MRIs were analyzed blindly, without knowledge of patients' baseline characteristics or clinical outcomes mentioned above. OsiriX Lite software (version 7.0, Pixmeo, Geneva, Switzerland) was used to calculate tumor volume, assess tumor multifocality, and assess contact of the post-contrast enhancement of the GBM with the lateral walls of the lateral ventricle (VSVZ), medial edge of the hippocampus (SGZ), cortex, and corpus callosum (CC). These contact assessments are commonly performed in other studies [18, 24] ; examples are depicted in Fig. 1 . Both axial (typically ≤3 mm cuts) and reformatted coronal and sagittal sequences were used for these assessments. Although no consensus exists to denote tumor multifocality, it was designated here by the presence of two or more noncontiguous contrast-enhancing lesions separated by at least 2 cm. Contact status of patients with multifocal tumors was denoted according to presence or absence of a lesion contacting the VSVZ, SGZ, CC, or cortex. Tumor volume was calculated by delineating the outer edge of tumor contrast enhancement and using the semiautomated volume rendering function in OsiriX Lite. Tumor volumes of all multifocal lesions in a patient were summated. Postoperative T1-weighted contrasted MRIs were assessed for first radiographic evidence of tumor recurrence agreed by both a neuroradiologist and neuro-oncologist. Further, any emergence of noncontiguous recurrences was noted by examining all postoperative MRIs. All imaging was interpreted by an independent board-certified, subspecialized neuroradiologist without knowledge of the study rationale or hypotheses.
Data analysis
Data were analyzed and plotted using GraphPad Prism version 7.00 for Windows (GraphPad Software, San Diego, CA, USA). Distributions of age, KPS, tumor volume, and EOR were tested for normality with D'Agostino-Pearson omnibus K2 test and failed the normality test; hence, analyses to compare distributions of these variables were conducted with two-tailed Mann-Whitney U or Kruskal-Wallis tests. Frequencies of multifocal GBMs and distal recurrences were compared using two-tailed Fisher's exact test or chi-squared (X 2 ) test. Survival data were plotted using right-censored Kaplan-Meier curves and median survival times were calculated. If the time to death (OS) or radiographic progression (PFS) was unknown, it was censored at the time of last follow-up after diagnosis or at the time of last follow-up MRI, respectively. Multivariate Cox survival analyses were conducted using all variables with a p-value < 0.1 on univariate analyses. R version 3.3 (R Foundation for Statistical Computing, Vienna, Austria) was used to perform these analyses. Statistical significance α was set at 0.05 for all statistical analyses. For simultaneous, multiple hypothesis testing in multivariate Cox analyses, a Benjamini-Hochberg procedure was applied to control false discovery rate (FDR) [25] . The Benjamini-Hochberg critical value for a FDR was set conservatively at 5%. Nomograms of the multivariate Cox analyses were generated using R, utilizing the rms library (version 4.5). 
Results
Patient and tumor characteristics
Among the 207 patients, 111 had GBM contacting VSVZ (VSVZ+), 23 had SGZ+, 52 had CC+, and 164 had cortex+ GBMs. Age, preoperative KPS, EOR, and tumor volume distributive statistics together with the number of patients with multifocal GBMs and distal recurrences are plotted in Fig. 2 . These data are grouped based on radiographic tumor contact with the VSVZ, SGZ, CC, and cortex. Age and pre-operative KPS did not differ in patients with VSVZ+, SGZ+, CC+, and cortex+ GBMs compared to their respective non-contacting controls, except in patients with SGZ + GBMs who were noted to have a lower median KPS (p = 0.03; Fig. 2a, b) . While tumor volume did not significantly differ based upon whether GBMs contacted the cortex or not, the tumor volumes of VSVZ+, SGZ+, and CC+ GBMs were significantly larger than their respective controls (p < 0.0001, 0.03, <0.0001, respectively, Fig. 2c ). CC+ GBMs displayed a significantly increased frequency of multifocality (17.3 vs. 6.5% for CC− GBMs; p = 0.03) while VSVZ+ GBMs demonstrated a trend towards multifocality (12.6 vs. 5.2% for VSVZ− GBMs; p = 0.09). Patients with cortex+ and CC− GBMs overall received greater EORs compared to their respective controls; however, the number of GTRs did not significantly differ in patients with GBMs with or without VSVZ, SGZ, CC, or cortical contact (Fig. 2d) . No significant association was observed between tumor volume and EOR (p = 0.22; twotailed Kruskal-Wallis test).
Overall and progression free survival
Kaplan-Meier OS and PFS curves grouped based on radiographic tumor contact with VSVZ, SGZ, CC, and cortex are shown in Fig. 3 and their respective median survivals are listed in Supplemental Table S1 . Results of univariate and multivariate Cox survival analyses including all variables with p-values < 0.1 on univariate analyses are tabulated in Table 1 . Increasing age, lower KPS, lack of radiation, lack of chemotherapy, failure to achieve a GTR, and GBM contact with the VSVZ were independent predictors of lower OS. While CC contact was associated with lower OS in univariate analysis, it was not a significant predictor in multivariate analysis. Interestingly, of the 52 CC+ GBMs, 48 (92%) were also VSVZ+, while of the 155 CC− GBMs, only 63 (41%) were VSVZ+ (p < 0.0001; twotailed Fisher's test). Further, CC contact did not modify the effect of VSVZ+ GBMs on overall survival (Supplemental Figure S1 ). Whether CC contact modifies the effect of VSVZ− GBMs on survival could not be statistically computed due to the very low power of such analysis, as there were only four patients with VSVZ−/CC+ GBMs. A nomogram of the variables found to be significant in multivariate Cox analysis was created to show the relative clinical effect of each variable and its linear contribution in predicting OS in our cohort (Supplemental Figure S2 ; for interpretation and use, refer to Gorlia, et al., 2008 [26, 27] ). With regards to recurrence, only VSVZ contact significantly predicted PFS. Overall, the results presented in Table 1 were similar with regards to the significance of the variables in correlating with OS and PFS when patients treated in the pre-temozolomide era (before March 2015, when the drug received FDA approval) were excluded (data not shown). No significant differences were observed in the frequency of postoperative distant recurrences in VSVZ+, SGZ+, CC+ and cortex+ GBMs compared to their non-contacting controls.
VSVZ and cortical contact interactions
We categorized GBMs into four groups based on VSVZ and cortical contact as previously proposed [19] . Similar to this prior observation, [19] we also observed that VSVZ+/cortex+ GBMs were more likely to be multifocal (n = 10/81) compared to VSVZ−/cortex− GBMs (n = 0/13). However, when considering incidences of multifocality of VSVZ+/cortex− (n = 4/30) and VSVZ−/cortex + GBMs . Further, we observed no significant interaction between VSVZ and cortical contact status with respect to OS or PFS (Fig. 4 , Supplementary Table S2 ), consistent with other reports [21, 23] .
Discussion
We demonstrate in this study that radiographic contact of GBM with the neurogenic zone VSVZ is independently associated with earlier recurrence and decreased survival. Of the two neurogenic zones, these clinical effects were specific to the VSVZ but not the SGZ. Further, these outcomes were not associated with CC or cortical contact. We conclude that the VSVZ has unique properties that contribute to GBM pathobiology.
The finding that VSVZ contact specifically, rather than neurogenic zones generally, is a negative prognostic factor is surprising, as many microenvironmental factors are potentially common between these two regions. Both the VSVZ and SGZ neural stem cells are thought to be rich in specialized vascular contacts and to retain some neurogenic potential in the adult brain, suggesting a reservoir of proliferative signals [28, 29] . Although debated, [30] the density of proliferative cells and its age-related changes are similar between VSVZ and SGZ in humans [31] . However, anatomical distinctions between these two niches do include contact with the cerebrospinal fluid (CSF), which is extensive in the case of VSVZ and is a key feature of normal neural stem cells, and the presence of a "gap layer" filled with astrocytic processes in the VSVZ which emerges as neurogenesis declines postnatally [1, 2] . We hypothesize that either or both of these features might provide unique environments which support the growth of highly malignant cells through specific mechanistic stimuli (such as growth factors enriched in the CSF) or structural effects (e.g. providing an environment with fewer hindrances to invasion). Several observations support these hypotheses. For example, widespread dissemination of tumor cells through CSF or along the length of VSVZ has been hypothesized [19, 32, 33] . Indeed, we noted contrast enhancement of the ipsilateral ventricular ependymal surface in a subset VSVZ+ GBMs (Supplemental Figure S3b-d) . MRI-identified ependymal tumor dissemination is also observed and reported in the literature and has been associated with shorter survival [34] . While studies have demonstrated VSVZ+ GBMs are associated with a greater frequency of distal recurrences [19, 22, 35, 36] , in our study, no difference was noted.
Interestingly, unlike SGZ, CC, and the cortex, we occasionally noted tumor contrast enhancement selectively and in a non-spherical growth extending towards and contacting the VSVZ (Supplemental Figure S3a, b) . Others have also noted this "stalk"-like contact [37] . Such tropism was not observed with SGZ, CC, or cortex. Indeed, in multiple orthotopic xenograft studies, GBM tumor cells have demonstrated this tropism for the VSVZ, [5] [6] [7] lending support to the hypothesis that VSVZ may have specific, intrinsic, tumor-supporting stimuli.
We cannot infer from our data that the greater tumor volume is caused by VSVZ contact, as the converse hypothesis is equally suggestive; i.e., VSVZ contact may be the eventual result of tumor growth. In fact, tumors with contact with all the radiographic variables studied-VSVZ, SGZ, CC, and cortex-exhibited larger volumes compared to their respective controls. These locations represent medial and lateral edges of the brain, and with tumor growth, these boundaries are increasingly likely to be contacted by the tumor.
GBM contact with the CC did not influence survival. Few studies, however, have demonstrated that patients with CC+ GBMs have decreased survival [8] [9] [10] [11] . Although the basis for this effect remains unclear, our analysis demonstrated a significant association of CC contact with VSVZ contact of GBMs (92% in this study). By nature of their anatomic proximity, VSVZ contact is likely coincident with CC contact in many cases, thus their analytic relationship with survival may demonstrate collinearity, confounding the survival outcome noted with CC contact. One recent study noted that 100% of the CC+ GBMs studied were also VSVZ+ GBMs, and that CC contact was not predictive of survival [18] .
Cortical contact of GBM was not predictive of extent of resection, tumor multifocality, distal recurrences, or survival. Therefore, our results demonstrated that categorizing GBMs as VSVZ+ and VSVZ− resulted in statistically similar clinical associations as categorizing GBMs into VSVZ+/cortex+, VSVZ+/cortex−, VSVZ−/cortex+, and VSVZ−/cortex−, as suggested originally by Lim, et al. [19] . However, this latter classification scheme continues to be used [20] [21] [22] [23] .
The results herein may be confined by the inherent limitations related to a retrospective study design encompassing a large time span. Hence, for a majority of the patients in this study (over 70%), the molecular status-MGMT promotor methylation and IDH mutation-of their GBMs is unknown. Therefore, this study cannot ascertain if the effects of VSVZ contact on survival are confounded by these molecular predictors. However, several studies have reported differences in MGMT promoter methylation [17, 35, 38] and IDH mutations [17, 23] Considering these limitations, this cohort represents one of the largest populations in which our unique hypothesis has been tested. Our results demonstrate that patients with GBMs contacting the VSVZ and SGZ neurogenic zones exhibit divergent clinical patterns of tumor recurrence and survival. Early recurrence and lower survival is specific to VSVZ but not SGZ. Our results indicate the necessity of dissecting the differential biological changes in GBMs contacting these two neurogenic zones and determining whether the worse outcome with VSVZ contact of GBMs is a manifestation of the VSVZ's neurogenic (i.e., stem cell and growth-factor rich microenvironment) or non-neurogenic (i.e., its strategic dissemination-promoting location with vascular and CSF access, and unique migration-supporting extracellular matrix [39] ) properties.
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